The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
In silico design of novel multitarget small molecule inhibitors to treat PTEN-mutant endometrial carcinoma.
 
Vaidehi Mujumdar
No Relationships to Disclose
 
Ritchie Delara
No Relationships to Disclose
 
Hailey L. Dryden
No Relationships to Disclose
 
Dhananjaya Pal
No Relationships to Disclose
 
Krishnaiah Maddeboina
No Relationships to Disclose
 
Page Mangum Arditti
No Relationships to Disclose
 
Bharath Yada
No Relationships to Disclose
 
R. Wendel Naumann
Consulting or Advisory Role - Agenus; AstraZeneca; Bristol-Myers Suibb; Eisai; EMD Serono; Genelux; GlaxoSmithKline/Tesaro; GOG Partners; Immunogen; Laekna Therapeutics; Merck Sharp & Dohme; Seagen; Sutro Biopharma
Speakers' Bureau - Seagen
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline/Tesaro (Inst); Gynecologic Oncology Group (Inst); Mersana (Inst); OncoMed (Inst); Sutro Biopharma (Inst)
 
Yovanni Casablanca
Speakers' Bureau - AstraZeneca
 
Erin Crane
Consulting or Advisory Role - AstraZeneca
 
Jubilee Brown
Speakers' Bureau - Genentech; GlaxoSmithKline/Tesaro
 
Donald Durden
Stock and Other Ownership Interests - SRX Pharmaceuticals
 
Cody McHale
No Relationships to Disclose